Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ibio Inc IBIO

Healthcare Biotechnology
iBio, Inc. is a preclinical stage biotechnology company that leverages artificial intelligence (AI) for the development of precision antibodies. The Company develops biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard-to-target cancers and other diseases. Its StableHu... see more

Recent & Breaking News (NYSEAM:IBIO)

iBio Announces Participation in the H.C. Wainwright BioConnect Conference

GlobeNewswire January 4, 2022

iBio Announces Partial Adjournment of Annual Meeting of Shareholders to January 31, 2022

GlobeNewswire December 22, 2021

iBio Provides Information for Listening to the Virtual Annual Stockholder Meeting

GlobeNewswire December 21, 2021

iBio Announces Partial Adjournment of Annual Meeting to December 22

GlobeNewswire December 10, 2021

ISS Joins Glass Lewis in Recommending Shareholders Vote "FOR" All Proposals Ahead of iBio's Upcoming Annual Meeting

GlobeNewswire November 30, 2021

Omicron Variant Underscores Need for New COVID Vaccine Candidates Like IBIO-202

GlobeNewswire November 29, 2021

Leading Independent Proxy Advisory Firm, Glass Lewis, Recommends iBio Shareholders Vote "FOR" All Proposals Ahead of Annual Meeting

GlobeNewswire November 17, 2021

iBio Reports Fiscal First Quarter 2022 Financial Results and Provides Corporate Update

GlobeNewswire November 15, 2021

iBio Announces Collaboration with UT Southwestern to Investigate IBIO-100 in Solid Tumors

GlobeNewswire November 15, 2021

iBio to Report Fiscal 2022 First Quarter Financial Results and Provide Corporate Update on Monday, November 15, 2021

GlobeNewswire November 8, 2021

iBio Acquires FastPharming Manufacturing Facility®

GlobeNewswire November 3, 2021

iBio Urges Shareholders to Vote "FOR" All Proposals Ahead of its Upcoming Annual Meeting to be Held on December 9

GlobeNewswire October 26, 2021

iBio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Corporate Update

GlobeNewswire September 27, 2021

iBio to Participate in the Cantor 2021 Virtual Global Healthcare Conference

GlobeNewswire September 20, 2021

iBio to Report Fiscal Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update on Monday, September 27, 2021

GlobeNewswire September 20, 2021

iBio Announces Participation in H.C. Wainwright 23rd Annual Global Investment Conference

GlobeNewswire September 7, 2021

iBio Appoints William D. Clark to its Board of Directors

GlobeNewswire August 26, 2021

iBio Expands Immuno-Oncology Pipeline in AI Partnership with RubrYc Therapeutics

GlobeNewswire August 25, 2021

iBio Reports Successful Preclinical Immunization Studies with Next-Gen Nucleocapsid COVID-19 Vaccine Candidate

GlobeNewswire July 15, 2021

iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs

GlobeNewswire July 8, 2021